Subcutaneous RYBREVANT(amivantamab) delivers promising 45 percent overall response rate with median duration of response of 7.2 months in recurrent or metastatic head and neck cancer
Responses were rapid and durable, and tumour shrinkage was observed in 82…
SOPHiA GENETICS Launches AI-Powered Digital Twins to Enhance Intelligent Decision-Making in Oncology
BOSTON and ROLLE, Switzerland, Oct. 16, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH),…
Roche presents new phase III pivotal data for vamikibart in uveitic macular edema (UME), a serious cause of vision loss
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving…
AM/NS India First to Secure CSIR-CRRI's Breakthrough Steel Slag Aggregates Technology License to Unlock 'Waste-to-Wealth' Potential in Road Infrastructure Development
This means company can apply the special technology developed by CSIR-CRRI to…
IFQM Symposium 2025 Concludes with a Call for Quality & Innovation to Make India Globally Competitive
India is at the cusp of developing and making products for the…
Pictor’s Proteomics Platform Offers Promising Advancement for Detecting Mycoplasma bovis in Cattle
New research highlights the Pictor PictVet™ Mycoplasma bovis IgG Multiplex ELISA's enhanced…
The Capital Link Announces Investigation Into the LuxUrban Story – The $300 Million Hotel Startup That Paid Workers 115% of Their Wages While the City Never Paid Up
San Diego, CA, Oct. 10, 2025 (GLOBE NEWSWIRE) -- The Capital Link is…
SKEMA presents UNVEIL, its 2025 – 2030 strategic plan
To unveil talents and transform societies PARIS, Oct. 9, 2025 /PRNewswire/ --…
UEG Week 2025: Microplastics found to change gut microbiome in first human-sample study
BERLIN, Oct. 7, 2025 /PRNewswire/ -- New research presented today at UEG Week…
University of Phoenix College of Doctoral Studies Releases White Paper on Aligning AI Innovation With Human Potential
Author Dr. Jessica Sylvester examines the “productivity paradox” and offers human-centered strategies…
